Sabichi AL - Search Results

1

The use of short tandem repeat profiling to characterize human bladder cancer cell lines.

Chiong E, Dadbin A, Harris LD, Sabichi AL, Grossman HB. Chiong E, et al. Among authors: sabichi al. J Urol. 2009 Jun;181(6):2737-48. doi: 10.1016/j.juro.2009.01.108. Epub 2009 Apr 17. J Urol. 2009. PMID: 19375735 Free PMC article.

2

Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.

Sabichi A, Keyhani A, Tanaka N, Delacerda J, Lee IL, Zou C, Zhou JH, Benedict WF, Grossman HB. Sabichi A, et al. J Urol. 2006 Mar;175(3 Pt 1):1133-7. doi: 10.1016/S0022-5347(05)00323-X. J Urol. 2006. PMID: 16469639

3

Clinical model of lifetime cost of treating bladder cancer and associated complications.

Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, Elting LS. Avritscher EB, et al. Among authors: sabichi al. Urology. 2006 Sep;68(3):549-53. doi: 10.1016/j.urology.2006.03.062. Epub 2006 Sep 18. Urology. 2006. PMID: 16979735

4

Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray.

Harris LD, De La Cerda J, Tuziak T, Rosen D, Xiao L, Shen Y, Sabichi AL, Czerniak B, Grossman HB. Harris LD, et al. Among authors: sabichi al. Mol Carcinog. 2008 Sep;47(9):678-85. doi: 10.1002/mc.20420. Mol Carcinog. 2008. PMID: 18288642 Free PMC article.

5

Clinical model of cost of bladder cancer in the elderly.

Cooksley CD, Avritscher EB, Grossman HB, Sabichi AL, Dinney CP, Pettaway C, Elting LS. Cooksley CD, et al. Among authors: sabichi al. Urology. 2008 Mar;71(3):519-25. doi: 10.1016/j.urology.2007.10.056. Urology. 2008. PMID: 18342201

6

Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.

Chiong E, Lee IL, Dadbin A, Sabichi AL, Harris L, Urbauer D, McConkey DJ, Dickstein RJ, Cheng T, Grossman HB. Chiong E, et al. Among authors: sabichi al. Clin Cancer Res. 2011 May 1;17(9):2863-73. doi: 10.1158/1078-0432.CCR-09-3202. Epub 2011 Mar 17. Clin Cancer Res. 2011. PMID: 21415218 Free PMC article.

7

Comparative outcomes of bladder cancer.

Cárdenas-Turanzas M, Cooksley C, Pettaway CA, Sabichi A, Grossman HB, Elting L. Cárdenas-Turanzas M, et al. Obstet Gynecol. 2006 Jul;108(1):169-75. doi: 10.1097/01.AOG.0000223885.25192.91. Obstet Gynecol. 2006. PMID: 16816072

8

Chemoprevention of superficial bladder cancer.

Gee J, Sabichi AL, Grossman HB. Gee J, et al. Among authors: sabichi al. Crit Rev Oncol Hematol. 2002 Sep;43(3):277-86. doi: 10.1016/s1040-8428(01)00190-1. Crit Rev Oncol Hematol. 2002. PMID: 12270783 Review.

9

Centrosomal abnormality is common in and a potential biomarker for bladder cancer.

Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL. Jiang F, et al. Among authors: sabichi al. Int J Cancer. 2003 Sep 20;106(5):661-5. doi: 10.1002/ijc.11251. Int J Cancer. 2003. PMID: 12866024

10

Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder.

Gee JR, Montoya RG, Khaled HM, Sabichi AL, Grossman HB. Gee JR, et al. Among authors: sabichi al. Urol Oncol. 2003 Jul-Aug;21(4):266-70. doi: 10.1016/s1078-1439(02)00271-5. Urol Oncol. 2003. PMID: 12954496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters